Lipid-protein interactions are rarely characterized at a structural molecular level due to technical difficulties; however, the biological significance of understanding the mechanism of these interactions is outstanding. In this report, we provide mechanistic insight into the inhibitory complex formation of the lipid mediator sphingosylphosphorylcholine with calmodulin, the most central and ubiquitous regulator protein in calcium signaling. We applied crystallographic, thermodynamic, kinetic, and spectroscopic approaches using purified bovine calmodulin and bovine cerebral microsomal fraction to arrive at our conclusions. Here we present 1) a 1.6-Å resolution crystal structure of their complex, in which the sphingolipid occupies the conventional hydrophobic binding site on calmodulin; 2) a peculiar stoichiometry-dependent binding process: at low or high protein-to-lipid ratio calmodulin binds lipid micelles or a few lipid molecules in a compact globular conformation, respectively, and 3) evidence that the sphingolipid displaces calmodulin from its targets on cerebral microsomes. We have ascertained the specificity of the interaction using structurally related lipids as controls. Our observations reveal the structural basis of selective calmodulin inhibition by the sphingolipid. On the basis of the crystallographic and biophysical characterization of the calmodulin-sphingosylphosphorylcholine interaction, we propose a novel lipid-protein binding model, which might be applicable to other interactions as well.-Kovacs, E., Harmat, V., Tó th, J., Vértessy, B. G., Mó dos, K., Kardos, J., Liliom, K. Structure and mechanism of calmodulin binding to a signaling sphingolipid reveal new aspects of lipid-protein interactions. FASEB J. 24, 000 -000 (2010). www.fasebj.org
ing events, regulating numerous proteins, including kinases, phosphatases, ion channels, and pumps (1) . CaM is a small (148 residues), acidic (pIϭ4.1), evolutionarily conserved protein, comprising homologous N-and C-terminal globular domains connected by a flexible central linker. Both domains possess a pair of ␣-helical Ca 2ϩ -binding EF-hand motifs (2) . Association with Ca 2ϩ induces the exposure of hydrophobic patches on CaM that allow binding of target proteins (3) ; in these complexes, CaM adopts a compact globular structure wrapped around its targets (4, 5) . Key modulation of CaM function via Ca 2ϩ binding was described decades ago. So far, no other second messenger has been shown to directly regulate CaM activity. The pharmacologic inhibitors of CaM are all synthetic aromatic molecules, of which trifluoperazine (TFP) is the most well characterized (6 -8) . There are reports on natural compounds presenting anti-CaM activity (9, 10) , but these substances can only be found in certain species; they are not universal to eukaryotic or even mammalian cells.
Previously, we have demonstrated that sphingosylphosphorylcholine (SPC), a putative lipid second messenger (11, 12) , can selectively bind to CaM and inhibit the protein's activity on target enzymes calcineurin and phosphodiesterase, while structurally similar lysophospholipid mediators, such as sphingosine-1-phosphate (S1P), lysophosphatidylcholine (LPC), and lysophosphatidic acid (LPA), showed no effect (13) . This finding proposes a novel type of endogenous regulation for CaM and also suggests an intracellular target for SPC, the newly recognized sphingolipid mediator. Information on SPC metabolism is rather scarce compared to the intensively studied S1P and ceramide, yet SPC has been detected under several physiological and pathological conditions (14 -17) .
Here, we give an in-depth structural and mechanistic characterization of CaM binding to SPC. We believe that our results largely contribute to the understanding of lipid-protein interactions and that the inhibitory CaM-SPC complex might be of particular importance in cellular signaling.
MATERIALS AND METHODS

Preparation of CaM and SPC solutions
CaM was purified from bovine brain according to Gopalakrishna and Anderson (18) , using phenyl-Sepharose affinity chromatography as the main purification step. d-erythro-sphingosylphosphorylcholine was purchased from Avanti Polar Lipids (Alabaster, AL, USA) and was delivered from a 10 mM methanolic stock solution.
X-ray crystallography
CaM and SPC were cocrystallized using the sitting drop method at room temperature. Protein solution (2 l) at 1 mM concentration was mixed with an equal volume of precipitant solution and 10 mM SPC solution in methanol, as well as 1.5 l 0.5% LM agarose gel. The precipitant solution was 50 mM sodium cacodylate adjusted to pH 5.5 and containing 10 mM CaCl 2 , 10 mM MgCl 2 , and 28% (w/v) polyethylene glycol 8000. Microseeding was carried out 24 h after setting up crystallization. The cryosolution contained 10% glycerol.
Data were collected at the ID 23-1 beamline of the European Synchrotron Radiation Facility. Wavelength of the beam was 0.97620 Å, and temperature was set to 100 K. Data were processed using Mosflm (19) and scaled using the SCALA program (20) . The crystals are isostructural with structures of CaM complexed with various small molecules (TFP, arylalkylamine).
The structure was solved by molecular replacement using the program MOLREP (21) of the Collaborative Computational Project 4 (22) . The N-and C-terminal CaM domains of PDB entry 1LIN were used as search models. Refinement was carried out with the REFMAC5 program, using TLS refinement and restrained maximum likelihood refinement (23) . One TLS domain was defined for both CaM domains and one for the SPC molecules. Hydrogen atoms were generated in the riding positions. Model building was carried out using the Coot program (24) .
The final model contains CaM residues 3-78 and 80 -146, with 12 disordered side chains and 3 side chains in alternate positions, as well as 4 calcium ions, 4 SPC molecule fragments, and 79 water molecules. The stereochemistry of the structure was assessed with PROCHECK (25), 94.4 and 5.6% of the CaM residues are in the most favored and additional allowed regions of the Ramachandran plot, respectively. Data collection and refinement statistics are shown in Table 1 . The atomic coordinates and structure factors were deposited in the PDB with accession code 3IF7.
Isothermal titration calorimetry
Thermodynamics of the interaction of Ca 2ϩ CaM and apoCaM with SPC was examined using a VP-ITC instrument (MicroCal, Piscataway, NJ, USA). Five-to 10-l aliquots of the protein at a concentration of 300 or 75 M in a buffer containing 10 mM HEPES, pH 7.4; 100 mM KCl; and either 5 mM CaCl 2 or 1 mM EGTA was injected into the ITC cell containing 200 M SPC in the same buffer at 25°C. A time interval of 10 minutes was applied between injections. The analysis of titration curves and the energetics calculations were done using the Origin software provided by MicroCal.
Dynamic light scattering
Size distributions of SPC-CaM solutions were assessed by an ALV goniometer with a Melles Griot diode-pumped solidstate laser at 457.5 nm wavelength (type: 58 BLD 301). The intensity of the scattered light was measured at 90°at room temperature. The autocorrelation function was calculated using an IBM PC-based data acquisition system developed in the Institute of Biophysics and Radiation Biology, Semmelweis University. The most probable particle distribution was estimated using the maximum entropy method that produces normalized distribution (26) . The hydrodynamic radii of the particles were calculated based on the Einstein-Stokes equation. Size distributions calculated in this manner bear a se of Ͻ5%. Micelle size distribution is essentially independent of total SPC concentration (27); we therefore optimized SPC concentrations for the best signal-to-noise ratios.
ANS fluorescence
Micelle integrity was monitored using the fluorescent hydrophobic probe 8-anilinonapthalene-1-sulfonic acid Values in parentheses are for highest-resolution shell. a A highresolution and a low-resolution data set were collected from the same crystal and were merged.
b Net B factors are sum of the residual and TLS contributions.
(ANS; Fluka 10417; Sigma-Aldrich, St. Louis, MO, USA) (28) on a Jobin Yvon Fluoromax-3 spectrofluorometer (Jobin Yvon Horiba, Longiumeau, France) at 25°C. 5 M ANS in a solution of 200 M SPC; 10 mM HEPES, pH 7.4; 100 mM KCl; and either 5 mM CaCl 2 or 1 mM EGTA was titrated with CaM in a concentration range of 0.1-20 M in case of apoCaM and 0.1-40 M in case of Ca 2ϩ CaM. The fluorophore was excited at 388 nm; emission was monitored from 400 to 600 nm. The excitation slit was adjusted to 2 nm, the emission slit was adjusted to 5 nm, and the maximum intensities were read.
Stopped-flow measurements
Dansyl-CaM was prepared according to Kovacs et al. (13) . Fluorescence time courses were recorded at 25°C in buffers 10 mM HEPES, pH 7.4; 100 mM KCl; and either 5 mM CaCl 2 or 1 mM EGTA, using an SX-20 (Applied Photophysics, Surrey, UK) stopped-flow apparatus having 2 ms dead time. Dansyl fluorescence was excited at 340 nm, and emission was selected with a 455-nm long-pass filter. At least 5 individual curves were collected and averaged for each data point. Time courses were analyzed using the curve-fitting software provided with the stopped-flow apparatus or by Origin 7 (OriginLab Corp., Northampton, MA, USA). The amplitude vs. concentration curves were fitted with the following quadratic equation 
where [AB] is the concentration of the complex, s is y at x ϭ 0, Amp is amplitude, c is the concentration of the constant component, and K is the dissociation constant.
Measurement of CaM binding to its cerebral microsomal targets
Cerebral microsomes were isolated from bovine brain by differential centrifugation based on the procedure of Volpe et al. (30) . The interaction between microsomal proteins and CaM was monitored using the fluorescence of dansyl-labeled CaM in a Jobin Yvon Fluoromax-3 spectrofluorometer at 25°C in 10 mM HEPES, pH 7.4; 100 mM KCl; and 1 mM CaCl 2 . Bandwidths were set to 5 nm. Dansyl was excited at 340 nm; emission was monitored from 400 to 600 nm. Microsomal protein and dansyl-CaM concentrations were 0.5 mg/ml and 0.2 M, respectively. Each spectrum was corrected for corresponding lipid, protein, and buffer effects by subtracting a matching buffer scan.
RESULTS
Crystal structure of the Ca
2؉
CaM/SPC complex
The crystal structure of the Ca 2ϩ CaM/SPC complex was refined to 1.6 Å resolution (Fig. 1) . The protein is well defined by electron density, except for the central linker region and the ends of the protein chain known to be highly flexible and often disordered in CaM structures (4 -6, 31) . The protein is in a collapsed conformation with a binding channel of mainly hydrophobic character formed between its two domains. The hydrophobic pockets known to be adaptable to the bound ligand are open.
Four SPC molecules could be identified in the calculated electron density maps (Supplemental Fig. S1 ). Their most rigid parts are the long extended alkyl chains bound in nearly parallel positions. The binding channel between the two calmodulin domains is filled by these four chains. Parts of SPC molecules farther from the center of the complex show higher mobility with their B-factor values similar to the central linker region of the protein (Fig. 2) . The alkyl chains of the sphingosyl moiety spread outside the binding channel (ϳ17 Å long), and the overhangs are disordered. The phosphocholine moieties could be built in electron density maps fully for two SPC molecules and partially for the third one; however, they show significantly lower electron density than the alkyl chains. Two of the SPC molecules are bent near their phosphate moieties and fill the hydrophobic pockets of CaM, while their positively charged choline groups are pointing toward the acidic regions of CaM, forming electrostatic interactions. The strongest electrostatic interactions of these charged choline groups are established with Glu11 and Glu127 (2.9 -3 Å), as well as with Glu54 and Glu123 Most importantly, the overall conformation of CaM is well defined in our crystal structure and resembles its complexes with the small molecules TFP (8) and the arylalkylamine derivative AAA (6) and many of its peptide complexes (e.g., refs. 4, 5) (Fig. 3) . Accordingly, residues involved in SPC binding could be also mapped to the small molecule inhibitor and target peptide binding sites (Supplemental Fig. S2 ). In the Ca 2ϩ CaM/SPC complex, CaM is in a collapsed overall conformation with SPC molecules bound between the two CaM domains. The fact that the lipid occupies the same binding pocket as the target peptides of CaM explains competitive inhibition witnessed in the calcineurin functional assay (13) and in peptide-binding assays (29) .
Isothermal titration calorimetry provides clues for a 2-step binding model
During preliminary studies on the interaction between SPC and CaM (13), we have found that in order to efficiently bind to the protein, the lipid has to be clustered, that is, in vitro, it has to form micelles. We have determined the CMC of SPC to be 33 Ϯ 2 M (13) and estimated a micelle to consist of ϳ50 -150 monomers, based on geometric calculations. As a consequence of this mode of binding, the characterization of the interaction requires special treatment. Hence, instead of applying the conventional isothermal titration calorimetry (ITC) experimental setup of ligand injection, we injected the protein into the cell containing 200 M SPC. By keeping the lipid concentration constant, well above its critical micelle concentration, we avoided the heat effects caused by the change in the micellar state of the lipid.
In contrast to traditional CaM inhibitors, which bind only to Ca 2ϩ CaM (8, 32) , SPC binds both in the presence and absence of Ca 2ϩ (13) . Therefore, we carried out experiments with both Ca 2ϩ CaM and apoCaM (Fig. 4) . Parameters obtained from the fitting process are presented in Table 2 . ⌬H, ⌬S, and K d values correspond to the binding of one CaM molecule to one apparent binding site. Both titrations generated two clearly distinguishable binding processes. The binding of apoCaM to SPC was very similar to Ca 2ϩ CaM binding to the lipid, only it took place in a narrower concentration range, that is, with different stoichiometry (see inset in Fig. 4 ). In case of apoCaM, we observed an additional endothermic heat reaction, which gradually decreased during the whole experiment and overlapped with the two binding reactions (Supplemental Fig. S3 ). We interpreted this process as micelle rearrangement, the effect of which could be removed by subtraction for the whole concentration range, yielding an undistorted double-binding curve for data evaluation. Parameters given for the first process of the Ca 2ϩ CaM titration should be taken as approximate values (Table 2) , because the beginning of the reaction could not be resolved. In general, the observed stoichiometry range for the SPC-CaM interaction is similar to what we and others have found previously for other lipid-protein interactions (33, 34) .
The stoichiometry of the two binding processes enabled us to envisage the following scenarios. The first, stronger binding, for which the fitting process yielded a stoichiometry of 100 -200 SPC monomers/protein and a K d of 61 Ϯ 10 nM for Ca 2ϩ CaM, and a stoichiometry of 164 Ϯ 5 SPC monomers/protein and a K d of 2. CaM could then isomerize in a collapsed conformation wrapped around only a few SPC monomers, as we see it in our crystal structure. ApoCaM, on the other hand, follows a reaction with the stoichiometry of ϳ40 SPC monomers/protein. This stoichiometry would allow the binding of several apoCaM molecules to one micelle or, alternatively, the disintegration of micelles into smaller "parts" stabilized by the protein.
Considering the enthalpy and entropy values (Table  2) , we can conclude that both reactions are entropically largely unfavorable. A study of Brokx et al. (35) on target peptide binding by CaM revealed that binding can be either entropically or enthalpically driven, but even in the second case, it is only slightly unfavorable entropically with the highest ϪT⌬S value of approximately ϩ5 kcal/mol. In contrast, our titrations yielded ϪT⌬S values of ϩ46 and ϩ65 kcal/mol for the first reaction and ϩ15 and ϩ15.5 kcal/mol for the second reaction, in case of Ca 2ϩ CaM and apoCaM, respectively. Accordingly, our ⌬H values are larger compared to the results of Brokx et al. (35) who obtained ⌬H values between approximately Ϫ15 and ϩ15 kcal/mol in contrast to our Ϫ56 Ϯ 1 and Ϫ77 Ϯ 1 kcal/mol for the first reaction and Ϫ22.9 Ϯ 0.5 and Ϫ24.7 Ϯ 0.6 kcal/mol for the second reaction for Ca 2ϩ CaM and Table 2. apoCaM
SPC. The large differences in the thermodynamic properties between SPC-CaM and single ligand-CaM interactions could be explained by the different nature of the two interactions. In our experiments, the initial state of SPC is micellar, not monomeric, and instead of one ligand, a CaM molecule embraces several SPC molecules on binding.
Dynamic light scattering affirms that CaM first binds to SPC micelles, which are then disintegrated by the protein
To ascertain the size distribution profile of SPC-CaM mixtures of varying stoichiometries, dynamic light scattering (DLS) measurements were carried out (Fig. 5) . It is worth noting that the intensity dimension of the DLS data is not informative, since it is greatly influenced by the larger contaminating particles in the solution that vary from sample to sample. To compare the size distributions of the species present, curves were normalized to their area. The R h values of the peaks correspond to the average hydrodynamic radii of the particles, and are, therefore, the relevant values characterizing the size of a given particle. Samples of 40 M Ca 2ϩ CaM and 40 M apoCaM both gave homogenous size distributions of 3.3 nm and 2.6 nm hydrodynamic radii, respectively, in accordance with preceding reports (36) . A sample of pure SPC micelles revealed that micelles have an average hydrodynamic radius of 3.1 nm. In mixtures of 200 M SPC with 8 M Ca 2ϩ CaM or 3 M apoCaM (concentrations near the end of the first ITC phase), an increase in particle size could be observed compared to SPC-free Ca 2ϩ CaM and apoCaM (Fig. 5) 
ANS fluorescence reveals the disruption of SPC micelles by CaM
To further verify the proposed model, we monitored micelle integrity during titration with CaM. Under conditions identical to that of ITC experiments, we followed the fluorescence of the hydrophobic probe, ANS. As the intensity of ANS fluorescence increases greatly when incorporated into lipid micelles (28) , it is well suited to certify the presence of micelles in a solution. The change in ANS fluorescence in the presence of 200 M SPC on incremental addition of Ca 2ϩ CaM or apoCaM is depicted in Fig. 6 . It is clearly demonstrated that increasing protein concentration disrupts micelles; moreover, their disruption occurs in the same range of molar ratios (0.02-0.2 for Ca 2ϩ CaM and 0.01-0.05 for apoCaM) as the second phase of the ITC measurements. This observation along with the results of the DLS measurements strongly argues for the explanation that the second phase witnessed in ITC experiments is a micelle disintegration process.
Kinetic properties of the 2-step binding process
We previously determined several kinetic parameters of the CaM-SPC interaction but only at relatively low CaM-to-SPC ratios (29) . In the current study, we aimed at characterizing the processes seen in the ITC experiments and implicated by the obtained Ca 2ϩ CaM/SPC crystal structure. We carried out rapid mixing experiments with both apo and Ca 2ϩ -saturated dansyl-CaM binding to SPC micelles (Fig. 7) . The reaction of Ca 2ϩ CaM with SPC at the applied concentrations was too fast to be measured; the entire signal change was lost in the dead time of the stopped-flow apparatus (2 ms) . Therefore, we could analyze the final fluorescence levels but not the kinetics of the fluorescence change. In the case of apoCaM, however, we could obtain transients on binding to 50 M SPC (Fig. 7A) . Similarly to the changes previously observed in equilibrium measurements (13), we obtained a large fluorescence increase on binding. The intensity increase partitioned into three kinetically distinguishable phases. The first, fast phase can only be inferred from the shift in the initial observed fluorescence compared to the reaction with buffer as the time course is lost in the dead time. This fast, initial fluorescence increase has the largest amplitude of all phases and most likely represents the collision complex of a dansyl-CaM molecule with a micelle. The second phase displayed concentration dependence only above 1 M CaM concentration (Fig.  7B) . Below 1 M CaM, an apparently first-order process having a rate constant of 77 Ϯ 4 s Ϫ1 is observed. The concentration-dependent part of the curve can be fitted with a linear function with a second-order rate constant of 79 Ϯ 10 M Ϫ1 s Ϫ1 . The third kinetic phase appears also above 1 M CaM concentration and has a rate constant of 12 Ϯ 4 s Ϫ1 . The concentration dependence of the total fluorescence change (Fig. 7C, inset ) could be fitted with a quadratic function yielding an apparent K d ϭ 0.05 Ϯ 0.03 M. The apparent concentration of the interacting species from the quadratic fit is 0.36 M. Given that the SPC monomer concentration was 50 M, the interacting micelle should consist of 140 monomers, a number close to the one estimated from the ITC experiments (Table 2) . Considering the monophasic nature of the saturation curve and that the obtained K d and monomers/micelle ratio values are close to the ones observed in the first ITC binding phase, we presume that the dansyl fluorescence predominantly reports on this first process, and only a small-amplitude fraction reports on the second one. Therefore, the equilibrium constant of the two processes cannot be resolved, and the apparent K d lies in between the relevant ones of the ITC measurement (Table 2) . On the other hand, plotting the signal change in function of the molar ratios as done when displaying ITC data (Fig. 7D, inset) , it is apparent that the stoichiometry dependence of the second phase and the appearance of the third phase coincide with the appearance of the second ITC process at molar ratio ϭ 0.02. This may indicate that we can observe the binding of additional CaMs to the CaM-micelle complex (concentration-dependent second phase) and a subsequent conformational change coupled to it (third kinetic phase). These events are much slower than the formation of the initial complex likely involving only one CaM binding to a micelle.
The concentration and stoichiometry dependence of the total fluorescence change on Ca 2ϩ CaM binding to SPC can be seen in Fig. 7C , D, respectively. The smooth line through the data in Fig. 7C represents the best double quadratic fit yielding K d,1 ϭ 0.02 Ϯ 0.07 M and K d,2 ϭ 0.43 Ϯ 0.80 M. The large fitting errors restrain us to resolve only the order of magnitude of the two K d s, not their precise values. Nevertheless, two distinct processes can clearly be observed with a significant difference between the two dissociation constants. The apparent SPC concentrations from the quadratic fits (0.44 and 18 M) imply that the interacting entities consist of ϳ114 and ϳ3 monomers in the first and second process, respectively. Relative K d s and the monomer numbers of the CaM-interacting partners are close to the ones calculated from the ITC experiments, suggesting that we observed the same events in both experimental setups. Comparing Fig. 7D with Fig. 4 , it is even more striking that the same processes are observed using two utterly different techniques. Furthermore, the 3 SPC/Ca 2ϩ CaM ratio determined in solution is very close to the stoichiometry of the complex resolved in our crystal (4 SPC/Ca 2ϩ CaM) and inferred from the ITC experiments (7 SPC/Ca 2ϩ CaM). This implies that our observations in the crystal and in the solution phase apply to the same phenomenon and consistently describe a uniform system.
SPC disrupts the interaction between CaM and CaM-binding proteins of cerebral microsomes
To assess the possible functional consequences of the binding mechanism described here in detail, we explored the effect of SPC on CaM bound to its targets on a cerebral microsomal fraction mimicking the intracellular environment. We used dansyl-CaM to monitor the state of CaM in the preparation, because the fluorescence of dansyl-CaM increases when bound to target proteins compared to the free or SPC-bound form (29, 37) . Figure 8 reveals that in the presence of microsomes, dansyl-CaM exhibits increased fluorescence, while the addition of SPC suppresses intensity to the level of dansyl-CaM bound to SPC alone. These results indicate that the addition of SPC to cerebral microsomes displaces CaM from its targets. The displacement is selective to SPC as other structurally related lysophospholipids, such as LPC or LPA, did not show the effect (Fig. 8A) . The dose response for SPC yielded an IC 50 of 94.4 Ϯ 2.2 M (Fig. 8B) . This value is ϳ5-fold higher than we would expect from peptide binding assays (29) and also higher than one would estimate cellular SPC levels to be. However, we should take into account the significant amount of endogenous CaM (and other possible SPC-binding proteins) in such cellular fractions, and that all CaM, endogenous and dansyl-labeled, should equally be displaced from its targets in order to get a complete signal from the dansyl fluorophore. We should also keep in mind that CaM regulation by SPC is most probably a highly localized one, and therefore, it does not require the inhibition of a large amount of CaM-target interactions globally, as in our experimental setup.
DISCUSSION
Previously, we have shown that the putative lipid second messenger SPC is capable of selectively inhibiting CaM in vitro (13) . This finding is of particular importance, as it proposes an intracellular target site for SPC and also suggests an utterly novel type of in vivo regulation for the well-known Ca 2ϩ sensor protein CaM. The so far characterized CaM inhibitors are all synthetic (6 -8) or occur only in specific species (9, 10) , while SPC is presumably present in most eukaryotic cells as an intermediate of sphingolipid metabolism (11, 12) . Moreover, we have demonstrated that SPC can bind to CaM efficiently only if it is clustered, which form is manifested in micelles in vitro, raising several intriguing questions about lipid-protein interactions. It is for the above reasons that we examined the CaM-SPC interaction using several independent biochemical and biophysical methods that allow evaluation of distinct features of the binding process. On the basis of our results, we propose a complex and consistent model of CaM binding to SPC both in the presence and absence of Ca 2ϩ .
As Ca 2ϩ
CaM is the functionally more important and better-characterized species, we present a detailed model on the Ca 2ϩ CaM-SPC interaction (Fig. 9) . Both ITC and stopped-flow measurements revealed a strong binding of Ca CaM to SPC (K d of 60 nM and 20 nM, respectively) with a stoichiometry, suggesting that the protein binds to micelles (values of 100 -200 and 114 SPC/Ca 2ϩ CaM, respectively). DLS measurements verified this concept as the size of this species was determined to be significantly larger than SPC micelles or CaM alone. The driving force of this interaction is probably an electrostatic attraction between the positively charged choline groups of SPC and the negatively charged residues of CaM. This notion is aided by the fact that SPC micelles are supposedly perceived as positively charged spheres with their hydrophobic carbon chains buried inside, and also that this phase was shown to be entirely enthalpically driven in ITC experiments.
ITC and stopped-flow measurements also demonstrated that a second process takes place during binding of Ca 2ϩ CaM to SPC micelles, which occurs when micelles become limiting. This second process results in a complex with an estimated stoichiometry of 3-7 SPC monomers/protein. As our crystal structure of the Ca 2ϩ CaM/SPC complex revealed that Ca 2ϩ
CaM can adopt a collapsed conformation wrapped around a few SPC molecules (4 in our structure), we hypothesized that the species resulting from the second process is identical to the one that we see in the crystal structure. This concept was supported by DLS experiments since the size of this species was significantly smaller than micelles or the protein alone. Furthermore, fluorescence measurements with ANS clearly demonstrated that micelles are disrupted during the second process. This species strikingly resembles the collapsed conformation of CaM, which the protein adopts on binding to target peptides or synthetic inhibitors CaM/SPC complex has been determined by X-ray crystallography. The figure was prepared using PyMol (DeLano Scientific). (Fig. 3) . Intriguingly, the peptide binding site of CaM is now occupied by several lipid molecules. Since the exact positions of the SPC headgroups were ambiguous to some extent in the crystal structure, hydrophobic interactions between the aliphatic chain of the lipid and the hydrophobic residues of the protein are more likely to contribute to the stabilization of this complex.
We envision that the surface of SPC micelles are coated by CaM, until there is not enough free space for the negatively charged protein to bind to the positive surface provided by the choline headgroups of SPC without sterically hindering each other (Fig. 9) . As micelles are dynamic structures, we propose that they fluctuate during the competition of CaM molecules for their positive surface, which leads to the appearance of the collapsed protein conformation engulfing several lipid monomers. CaM molecules embracing several SPC monomers continuously leave the micelle-protein complex, thus gradually resulting in disintegration of the micelle. It is important to emphasize that this scenario only pictures one possible way the two species (CaM bound to micelles and the collapsed conformation) might arise, other possibilities also exist. What we have demonstrated unambiguously is the stoichiometry-dependent appearance of the two species, both of which are inhibitory. The lipid shields the target peptide binding sites in both CaM conformations, resulting in an inhibitory effect in enzyme activity (13) and peptide-binding assays (29) .
The binding of apoCaM resembles that of Ca 2ϩ
CaM, as it can be described by similar two processes, but with a difference in the complex arising in the second phase. The apoCaM-SPC complex can be characterized by a stoichiometry of ϳ40 SPC monomers/protein and is larger than the one appearing in the presence of Ca 2ϩ . Presumably, this phenomenon can be explained by the fact that apoCaM is unable to adopt a collapsed conformation with a hydrophobic binding channel surrounded by acidic residues as Ca 2ϩ CaM can. The fact that apoCaM can bind to SPC makes SPC unique among CaM inhibitors since the classical CaM inhibitors are unable to bind to apoCaM (8, 32) . This special behavior might be explained by the fact that the binding of the protein to the micelle is almost entirely driven by electrostatic forces, as the hydrophobic chains of the lipid are buried within the micelle.
Hence, the open hydrophobic patches of the protein are not required in the initial stage of binding. In contrast, traditional aromatic inhibitors bind as monomers, offering mostly the possibility of hydrophobic interactions with CaM. The unique property of SPCthat it binds to both apo and Ca 2ϩ CaM-raises the possibility of an entirely new regulation of proteins that constitutively bind CaM (38) .
We have demonstrated that SPC is capable of displacing CaM from its targets on cerebral microsomes, indicating that the interaction that we have structurally extensively characterized might have important implications in cellular signaling. A membrane surface enriched in SPC might serve as an in vivo equivalent for the SPC surface presented by micelles in vitro. It is important to note that the precise affinity and stoichiometry values determined here characterize the protein-micelle system and should not be directly applied to cellular conditions. What our model reveals about the in vivo lipid-protein interaction is the following: 1) CaM interacts with SPC clusters at high (nanomolar) affinity; 2) once the SPC-CaM complex forms, it can adopt different conformations depending on several factors, most likely on the curvature and size of the lipid cluster and the local abundance of CaM. The fact that the interaction can manifest itself in both mixed lipid (13, 29) and protein (measurements on cerebral microsomes) environments points to the plausibility of the same phenomenon to occur under cellular conditions.
In summary, we present a structural model for the binding of CaM to the lipid mediator SPC. At low protein-to-lipid ratios, CaM binds to intact micelles, whereas at high protein-to-lipid ratios micelles are disintegrated by the protein, eventuating in a compact globular conformation of Ca 2ϩ CaM, also visualized in our crystal structure. Both the micelle-bound and the collapsed conformation are inhibitory, as the lipid shields the binding sites for target peptides, potentially having important consequences in cell signaling. Moreover, this unique 2-step binding model describes a novel and peculiar biochemical mechanism, which reveals how versatile a lipidprotein interaction can be.
